—

Lantheus Holdings Inc(LNTH)— 同类公司组

数据截至2026-11-20 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Lantheus Holdings Inc的Closelook综合评分为59/100,在同类公司组内排名第2位(共7家)——组内评分最高的是Laboratorios Farmaceuticos ROVI(62/100)。

名称综合动量质量估值信号距52周高点
LNTH Lantheus Holdings Inc59747352ok8.7%
ROVI.MC Laboratorios Farmaceuticos ROVI62577442info26%
IRWD Ironwood Pharmaceuticals Inc58767782info18.7%
KNSA Kiniksa Pharmaceuticals Ltd58966117ok5.5%
GALDY GALDERMA GROUP AG56705921ok9.8%
BHC.TO Bausch Health Companies Inc55945084ok6.7%
FAGR.BR Fagron NV55755555ok2.6%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-11-20

Quick answers

Lantheus Holdings Inc在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Ironwood Pharmaceuticals Inc (IRWD)、Kiniksa Pharmaceuticals Ltd (KNSA)、GALDERMA GROUP AG (GALDY)、Bausch Health Companies Inc (BHC.TO)、Fagron NV (FAGR.BR)。

LNTH相对同类公司的评分如何?

Lantheus Holdings Inc的综合评分为59/100,组内排名第2位(共7家),截至2026-11-20;组内最高综合评分为Laboratorios Farmaceuticos ROVI(62/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.